Susquehanna International Group, LLP Kodiak Sciences Inc. Put Options Transaction History

Susquehanna International Group, LLP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 11, 2023	BUY	$4.3 - $9.48 $62,350 - $137,460	14,500 New	14,500 $100,000
Q4 2022 Feb 14, 2023	SELL	$6.52 - $8.05 $1.29 Million - $1.59 Million	-197,400 Reduced 93.33%	14,100 $100,000
Q3 2022 Nov 14, 2022	BUY	$7.57 - $12.5 $1.3 Million - $2.14 Million	171,100 Added 423.51%	211,500 $1.64 Million

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.